Search

Author/Creator Dolbeau, G

1. C06 The β-catenin repressor GSK-3β is a modifier of age at onset in Huntington's disease. (16th November 2010)

Authors:
Parker, J A; Tourette, C; Offner, N; Vazquez-Manrique, R; Mukhopadhyay, A; Darbois, A; Menet, S; Dolbeau, G; Schwenke, S; Maison, P; Orth, M; Brice, A; Dürr, A; Bachoud-Lévi, A-C; Tissenbaum, H A; Néri, C
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 81(2010)Supplement 1
Page Start:
A17
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. L03 Use and impact of neuroleptics in Huntington's disease: a prospective cohort study of the Huntington French speaking group. (16th November 2010)

Authors:
Dolbeau, G; Lombard, A; Youssov, K; Dürr, A; Charles, P; Verny, C; Azulay, J-P; Krystkowiak, P; Simonin, C; Tranchant, C; Goizet, C; Damier, P; Supiot, F; Broussolle, E; Démonet, J-F; Marie, R-M; Verin, M; Bachoud-Lévi, A-C; Maison, P
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 81(2010)Supplement 1
Page Start:
A48
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Meta-analysis of individual-patient data from EVAR-1, DREAM, OVER and ACE trials comparing outcomes of endovascular or open repair for abdominal aortic aneurysm over 5 years. Issue 3 (3rd February 2017)

Authors:
Powell, J T; Sweeting, M J; Ulug, P; Blankensteijn, J D; Lederle, F A; Becquemin, J-P; Greenhalgh, R M; Greenhalgh, R M; Beard, J D; Buxton, M J; Brown, L C; Harris, P L; Powell, J T; Rose, J D G; Russell, I T; Sculpher, M J; Thompson, S G; Lilford, R J; Bell, P R F; Greenhalgh, R M
Journal:
British journal of surgery
Issue:
Volume 104:Issue 3(2017)
Page Start:
166
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗